Duration of IPV Priming and Antibody Decay

NCT03202719 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
1645
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

Centers for Disease Control and Prevention

Collaborators